Consistent with TcPO2 monitoring results, lower expression level of Hif-1a was observed 48 hours after flap elevation at zone IV when arterial rather than venous supercharging was used, implying its higher anti-ischemia efficacy. This evidence concerns the gene HIF1A and ischemia.